Cantex Pharmaceuticals, Inc. Chimerix Inc (CMRX) insider trading activity
Cantex Pharmaceuticals, Inc. is > 10% Shareholder of CHIMERIX INC. Currently has a direct ownership of 3.5 Million shares of CMRX, which is worth approximately $11.9 Million. The most recent transaction as insider was on Sep 14, 2021, when has been sold 6,500,000 shares (Common Stock, par value $0.001) at a price of $5.75 per share, resulting in proceeds of $37,375,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
3.5M
0%
3M change
0%
12M change
Total Value Held
$11.9 Million
CPI
Cantex Pharmaceuticals, Inc.
> 10% Shareholder
Weston, FL